Immune thrombocytopenia (ITP) trials in Poland

In Poland 11 Also abroad 118

11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Where
Gdansk, Lodz, Skorzewo, Slupsk
Age
18 years and over
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07007962 · EU 2025-522070-36-00
Phase 1/2Taking people
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Where
Cracow, Katowice, Skorzewo, Torun
Age
18 years to 64 years
People
68 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06721013 · EU 2024-518502-40-00
Phase 3Taking people
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Where
Katowice, Lodz, Warsaw
Age
18 years and over
People
171 worldwide
Run by
Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00
Phase 1Taking people
Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
Where
Warsaw
Age
18 years and over
People
78 worldwide
Run by
Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00
Phase 3Taking people
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Where
Katowice, Lodz, Warsaw
Age
18 years and over
People
150 worldwide
Run by
Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00
Phase 2/3Taking people
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Where
Cracow, Gdansk, Lodz, Lublin, Warsaw
Age
12 years to 17 years
People
24 worldwide
Run by
argenx
See details and how to joinNCT07194850 · EU 2025-521055-23-00
Phase 2Taking people
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
Where
Katowice, Skorzewo
Age
18 years to 80 years
People
30 worldwide
Run by
Nuvig Therapeutics, Inc.
See details and how to joinNCT07095127 · EU 2024-520359-26-00
Phase 1Taking people
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Where
Warsaw
Age
18 years to 85 years
People
144 worldwide
Run by
Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00
Phase 1Enrolling by invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Where
Warsaw
Age
18 years to 85 years
People
144 worldwide
Run by
Chugai Pharmaceutical
See details and how to joinNCT06723106
Phase 1Taking people
A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911
Where
Warsaw
Age
18 years to 64 years
People
76
Run by
Qilu Pharmaceutical Co. Ltd.
See details and how to join2025-523355-59-00
Phase 3Taking people
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Where
Bydgoszcz, Katowice, Lodz, Lublin, Nowy Sacz, Torun
Age
18 years and over
People
69 worldwide
Run by
argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00